AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

STANDARD BIOTOOLS INC. Director's Dealing 2022

Apr 7, 2022

32853_dirs_2022-04-06_2171562d-62cb-4414-bb55-906becc8c54e.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-04-04

Reporting Person: Egholm Michael (Director, President & CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct